Daniela Bursacovschi | Cardiology | Innovative Research Award

Innovative Research Award

Daniela Bursacovschi
Affiliation PSMI Institute of Cardiology
Country Moldova
Google Scholar ID PJ87zScAAAAJ
Citations 4045
h-index 5
i10-index 4
Subject Area Cardiology
Event Global Academic Awards

Daniela Bursacovschi

PSMI Institute of Cardiology, Moldova

The Innovative Research Award profile recognizes the scholarly achievements and research contributions of Daniela Bursacovschi, affiliated with the PSMI Institute of Cardiology in Moldova. Her academic activities are associated with cardiology research, scientific dissemination, and participation in internationally recognized scholarly initiatives. The profile highlights research productivity, citation performance, and contributions to evidence-based cardiovascular science.[1] The recognition aligns with the objectives of the Global Academic Awards in promoting impactful and innovative academic research across disciplines.[2]

Abstract

This academic recognition article presents an overview of Daniela Bursacovschi’s scholarly profile, institutional affiliation, and research influence within the field of cardiology. The profile evaluates research visibility through citation metrics, publication activity, and engagement with academic communities. Recognition through the Innovative Research Award reflects scholarly commitment to advancing cardiovascular knowledge and fostering scientific excellence within contemporary medical research.[1][3]

Keywords

Cardiology, Cardiovascular Research, Innovative Research Award, Scientific Impact, Medical Research, Citation Analysis, Research Excellence, Academic Recognition, Global Academic Awards, Scholarly Contributions.

Introduction

Academic awards serve as mechanisms for recognizing excellence in research, innovation, and scholarly communication. Within the biomedical sciences, cardiology remains a critical field addressing cardiovascular disease prevention, diagnosis, and treatment. Researchers who contribute to scientific understanding through publications, collaborations, and evidence-based investigations support the advancement of patient care and healthcare systems worldwide.[4] Daniela Bursacovschi’s academic profile reflects engagement with these objectives through measurable scholarly outputs and recognized scientific contributions.[1]

Research Profile

Daniela Bursacovschi is affiliated with the PSMI Institute of Cardiology, Moldova, where her academic interests are associated with cardiovascular medicine and related clinical research domains. Her scholarly profile demonstrates visibility within the scientific community through indexed publications and citation activity. Citation-based indicators, including an h-index of 5 and an i10-index of 4, provide quantitative measures of research influence and dissemination.[1]

Research Contributions

Research contributions associated with Daniela Bursacovschi emphasize the importance of evidence generation within cardiology. Such work contributes to the broader scientific effort aimed at improving cardiovascular outcomes, refining diagnostic methodologies, and supporting translational applications in clinical practice. Scholarly engagement in these areas enhances interdisciplinary collaboration and promotes the integration of scientific findings into healthcare decision-making processes.[4][5]

Publications

The publication record associated with the research profile demonstrates participation in scholarly communication through peer-reviewed outputs and citation-indexed academic work. Publications provide a foundation for disseminating research findings, facilitating reproducibility, and supporting future investigations. The visibility of published research contributes to cumulative scientific progress and knowledge transfer across the cardiovascular research community.[1]

Research Impact

Research impact may be evaluated through citation metrics, scholarly engagement, and the influence of scientific findings on future studies. With a citation count of 4045, Daniela Bursacovschi’s academic profile reflects notable research visibility and engagement within relevant scientific networks. Citation performance serves as one indicator of knowledge dissemination and scholarly relevance while complementing qualitative assessments of research significance and innovation.[1]

Award Suitability

The Innovative Research Award recognizes researchers whose academic activities demonstrate originality, scientific engagement, and measurable scholarly impact. Daniela Bursacovschi’s research profile aligns with these objectives through documented citation performance, publication activity, and ongoing contributions to cardiology research. Such achievements support the principles of excellence, innovation, and international scholarly collaboration promoted by the Global Academic Awards.[2]

Conclusion

Daniela Bursacovschi’s academic profile illustrates a commitment to scholarly inquiry and the advancement of cardiovascular research. Through research dissemination, citation visibility, and contributions to scientific knowledge, the profile reflects characteristics commonly associated with academic excellence. Recognition through the Innovative Research Award acknowledges these accomplishments and highlights the continuing importance of research-driven innovation in cardiology.[1][2]

References

  1. Google Scholar. (n.d.). Scholar profile: Daniela Bursacovschi, User ID PJ87zScAAAAJ. Google Scholar.
    https://scholar.google.com/citations?user=PJ87zScAAAAJ&hl=en&oi=ao
  2. Global Academic Awards. (n.d.). International academic recognition and award program.
    https://globalacademicawards.com/
  3. Elsevier. (2023). Research assessment and scholarly metrics in modern academia.
  4. European Society of Cardiology. (2024). Cardiovascular research priorities and scientific advancement.Β 
  5. Nature Reviews Cardiology. (2023). Translational cardiovascular medicine and clinical innovation.

Vahid Eslami | Cardiology | Best Researcher Award

Assoc. Prof. Dr. Vahid Eslami | Cardiology | Best Researcher Award

Assoc. Prof. Dr. Vahid Eslami, Shahid Modarres hospital, Iran

Assoc. Prof. Dr. Vahid Eslami is a board-certified Interventional Cardiologist and Structural Heart Specialist based in Tehran, Iran. With over 14 years of experience, he specializes in high-risk coronary interventions, TAVI, CTO angioplasty, and advanced cardiac imaging (IVUS, OCT). πŸ₯ As Head of the Cardiovascular Department at Shahid Beheshti University, he leads clinical education and research, boasting 50+ peer-reviewed publications and an H-index of 11. πŸŽ“ A Fellow of the American College of Cardiology and member of ESC, EAPCI, and ISOIC, Dr. Eslami actively mentors cardiology trainees and presents at global cardiology congresses.

Publication Profile

Google Scholar

Professional Experience

Assoc. Prof. Dr. Vahid Eslami is a distinguished Interventional Cardiologist and Head of the Cardiovascular Department at Shahid Beheshti Medical University, Tehran. With over a decade of clinical and academic excellence, he has led multidisciplinary teams, performed over 500 complex coronary interventions, and implemented advanced imaging technologies like IVUS and OCT. πŸ“ˆ He has overseen impactful research, contributing to 20+ high-impact publications and international conference presentations. πŸ₯ As a medical educator, he has trained over 100 cardiology residents and fellows. πŸ§‘β€βš•οΈ A respected leader and national board member for myocardial infarction treatment, he actively shapes Iran’s cardiovascular protocols. 🌍

πŸŽ“ Education & Medical Training

Dr. Vahid Eslami completed his Doctor of Medicine (MD) at Tehran University of Medical Sciences (1999–2006), ranking 11th among 300,000 applicants in the national entrance exam. πŸ… He pursued a Cardiology Residency (2006–2010) at Shahid Beheshti University of Medical Sciences, where his thesis on QT dispersion post-primary PCI was published in a U.S. journal. πŸ«€ He then completed a Fellowship in Interventional Cardiology (2012–2014) at the same university, focusing on coronary angiography and FFR, with his research again featured in international journals. πŸ“˜ His training solidified his expertise in advanced cardiovascular care and research

πŸ… Licenses & Certifications

Dr. Vahid Eslami is a board-certified Interventional Cardiologist, accredited by the American College of Cardiology (ACC) πŸŽ“. He holds active memberships in several esteemed cardiology organizations, including the American College of Cardiology , the European Association of Percutaneous Cardiovascular Interventions (EAPCI) , and the Iranian Society of Interventional Cardiology (ISOIC) . These affiliations reflect his global engagement and adherence to the highest standards of cardiovascular care.His certifications and memberships support his ongoing contributions to research, education, and innovation in interventional cardiology.

πŸ§ πŸ”¬ Research Focus

Assoc. Prof. Dr. Vahid Eslami’s research is deeply rooted in interventional cardiology, with significant contributions to COVID-19 cardiovascular outcomes , anticoagulation therapies, and ischemic heart disease. His studies focus on complex coronary interventions, QT interval dynamics, inflammatory biomarkers, and gender differences in cardiac risk. He’s actively involved in randomized controlled trials and has examined the visual-functional mismatch in coronary diagnostics. He also explores the role of epicardial fat and cardiac imaging indices in disease progression. His multidisciplinary work bridges clinical practice and cardiovascular research, advancing protocols for acute and critical care cardiology

Publication Top Notes

  • πŸ“„ Effect of intermediate-dose vs standard-dose prophylactic anticoagulation… – πŸ“Š738 citations | πŸ“…2021

  • πŸ“„ Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19… – πŸ“Š87 citations | πŸ“…2022

  • πŸ“„ Atorvastatin versus placebo in patients with covid-19 in intensive care… – πŸ“Š76 citations | πŸ“…2022

  • πŸ“„ Evaluation of QT, QT dispersion, and T-wave peak to end time changes… – πŸ“Š61 citations | πŸ“…2013

  • πŸ“„ Association of CT-measured cardiac indices with lung involvement in COVID-19 – πŸ“Š48 citations | πŸ“…2021

  • πŸ“„ Are women more susceptible to ischemic heart disease? A literature overview – πŸ“Š36 citations | πŸ“…2021

  • πŸ“„ Epicardial adipose tissue, inflammatory biomarkers and COVID-19 – πŸ“Š31 citations | πŸ“…2021

  • πŸ“„ Extrinsic compression of left main coronary artery by the pulmonary trunk… – πŸ“Š28 citations | πŸ“…2009

  • πŸ“„ Management of STEMI during COVID-19: Iranian β€œ247” National Committee’s position paper – πŸ“Š26 citations | πŸ“…2021

  • πŸ“„ Prognostic value of inflammatory biomarkers in COVID-19 patients – πŸ“Š15 citations | πŸ“…2021

Anna Truong | Cardiology | Best Researcher Award

Ms. Anna Truong | Cardiology | Best Researcher Award

Pharmacist at Monash health, Australia

Anna Truong is a dedicated clinical pharmacist with extensive experience in cardiology, geriatrics, and intensive care πŸ«€πŸ’Š. She holds a Master of Clinical Pharmacy and multiple postgraduate certificates from Monash University πŸŽ“. Currently serving at the Victorian Heart Hospital, Anna actively contributes to patient care, clinical education, and multidisciplinary collaboration. Her roles have included research on medication titration for heart failure and involvement in the Virtual Hospital project. Known for her proactive and compassionate approach, she is committed to quality improvement and mentoring future pharmacists 🌟. Outside of work, she enjoys yoga, painting, and travelling πŸ§˜β€β™€οΈπŸŽ¨βœˆοΈ.

Publication Profile

Orcid

Academic Background

Anna Truong has a strong academic background in pharmacy and medicinal chemistry. She earned her Bachelor of Medicinal Chemistry, focusing on drug design and discovery, from Monash University Clayton/Parkville between 2006 and 2008 πŸ’ŠπŸ”¬. She then completed her Bachelor of Pharmacy with Honours at Monash University Parkville from 2009 to 2012. Further advancing her expertise, Anna attained graduate certificates in Geriatrics and Mental Health during 2015-2016 πŸ§ πŸ‘΅. Most recently, she completed a Master of Clinical Pharmacy from Monash University Parkville between 2018 and 2020, solidifying her clinical knowledge and skills to excel in patient care and research.

Professional Experience

Anna Truong is a dedicated pharmacist with diverse clinical experience across multiple health settings. Since March 2023, she has worked as a rotational pharmacist at the Victorian Heart Hospital, actively participating in cardiology ward rounds and educating new pharmacists and students πŸ₯❀️. From 2019 to 2023, she served at Monash Health Clayton, covering cardiology, intensive care, neurosurgery, and surgical areas, contributing to clinical projects and mentoring students πŸ¨πŸ“‹. Earlier roles include clinical pharmacist positions at Peninsula Health Frankston and Middlemore Hospital Auckland, where she supported geriatric and orthopaedic care, supervised pharmacy training, and enhanced medication safety πŸ§“πŸ”¬. Her early career included locum pharmacist and intern roles, providing patient-focused medication management across diverse clinical areas.

Awards and Honors

Anna Truong has been recognized for her dedication and excellence in clinical pharmacy. Throughout her career, she has received commendations for her leadership in cardiology pharmacy services and contributions to quality improvement projects πŸ’ŠπŸ‘. Her commitment to education and mentorship has earned her appreciation from both colleagues and students πŸŽ“πŸ€. Anna’s proactive approach in optimizing medication safety and patient care has been acknowledged in hospital award programs and pharmacy professional bodies πŸ₯πŸŽ–οΈ. These honors reflect her passion for advancing pharmacy practice and delivering exceptional healthcare outcomes.

Research Focus

Anna Truong brings extensive clinical expertise across Cardiology, Intensive Care, Neurosurgery, Surgery, General Medicine, and Geriatrics. She is deeply motivated to continuously learn and contribute to educating pharmacists, students, and interns, fostering exceptional patient care, especially in Cardiology πŸ«€πŸ“š. With excellent interpersonal and teamwork skills, she thrives in multidisciplinary environments, building strong professional relationships and mentoring future pharmacy professionals πŸ€πŸ‘©β€βš•οΈ. Anna approaches her work with reliability, energy, and a proactive mindset focused on quality improvement. She adapts swiftly to fast-paced settings and excels in time management and organization, ensuring deadlines and patient needs are met efficiently ⏱️⚑.

Publication Top Notes

The impact of a transition of care electronic medication titration plan on optimising the treatment of heart failure after hospital discharge πŸ«€πŸ’Š
Year: 2025 | Contributors: Anna Truong, Adeline Roussety πŸ“„βœ¨

Conclusion

Anna Truong is an outstanding candidate for a “Best Researcher Award” due to her leadership in clinically impactful research on electronic medication titration for heart failure, strong collaboration with multidisciplinary teams at Monash Heart, and active involvement in innovative projects like the Virtual Hospital and atrial fibrillation chatbot. Her extensive clinical experience across Cardiology, ICU, Geriatrics, and General Medicine, combined with her contributions to guideline development, education, and mentoring, demonstrate a deep commitment to advancing pharmacy practice. Coupled with her active role in quality improvement committees and professional credentials, Anna exemplifies excellence in clinical research and evidence-based care implementation.